MoneyWorks4Me

RPG Life Sciences - Quaterly Results

28 Jan 2026 Evaluate
The quarter ended December 2025 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 1800.30 millions.Net Profit of the company move down -36.64% to Rs. 221.30  millions from Rs. 349.30 millions  in the same quarter last year.A decline of 431.70 millions was observed in the OP in the quarter ended December 2025 from 524.70 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 1800.30 1727.10 4.24 5306.30 5103.40 3.98 6534.30 5820.50 12.26
Other Income 34.10 33.10 3.02 131.80 76.20 72.97 126.80 72.10 75.87
PBIDT 431.70 524.70 -17.72 1274.40 1417.80 -10.11 1723.30 1353.60 27.31
Interest 2.50 1.20 108.33 5.00 4.40 13.64 6.20 4.50 37.78
PBDT 345.00 523.50 -34.10 1297.40 1140.40 13.77 2543.10 1349.10 88.50
Depreciation 53.80 54.60 -1.47 157.40 160.60 -1.99 214.30 170.70 25.54
PBT 291.20 468.90 -37.90 1140.00 979.80 16.35 2328.80 1178.40 97.62
TAX 69.90 119.60 -41.56 287.30 320.90 -10.47 496.40 301.80 64.48
Deferred Tax 0.80 0.40 100.00 11.90 -1.20 -1091.67 -0.50 -23.60 -97.88
PAT 221.30 349.30 -36.64 852.70 658.90 29.41 1832.40 876.60 109.03
Equity 132.30 132.30 0.00 132.30 132.30 0.00 132.30 132.30 0.00
PBIDTM(%) 23.98 30.38 -21.07 24.02 27.78 -13.55 26.37 23.26 13.40
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..